Metabolisk kontrol med insulin hos patienter med diabetes mellitus og akut myokardieinfarkt (DIGAMI 2): effekt på mortalitet og morbiditet--sekundaerpublikation

Ida Gustafsson, Klas Malmberg, Lars Rydén, Hans Wedel, Kåre Birkeland, Aart Bootsma, Kenneth Dickstein, Suad Efendic, Miles Fisher, Anders Hamsten, Johan Herlitz, Per Rossen Hildebrandt, Kenneth MacLeod, Markku Laakso, Christian T Torp-Pedersen, Anders Waldenström, DIGAMI-2 investigatorerne

2 Citationer (Scopus)

Abstract

Patients with diabetes have an unfavourable prognosis after an acute myocardial infarction. The DIGAMI 2 study investigated the effect of various metabolic treatment strategies in type 2 diabetic patients with acute myocardial infarction: acutely introduced, long-term insulin treatment did not improve survival when compared with conventional management at similar levels of glucose control. However, good glucose control seems important since the glucose level was found to be a strong predictor of long-term mortality in this patient category.

Bidragets oversatte titelMetabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind168
Udgave nummer6
Sider (fra-til)581-4
Antal sider4
ISSN0041-5782
StatusUdgivet - 6 feb. 2006

Emneord

  • Aged
  • Blood Glucose
  • Diabetes Mellitus, Type 2
  • Female
  • Follow-Up Studies
  • Humans
  • Hypoglycemic Agents
  • Insulin
  • Male
  • Myocardial Infarction
  • Prognosis

Fingeraftryk

Dyk ned i forskningsemnerne om 'Metabolisk kontrol med insulin hos patienter med diabetes mellitus og akut myokardieinfarkt (DIGAMI 2): effekt på mortalitet og morbiditet--sekundaerpublikation'. Sammen danner de et unikt fingeraftryk.

Citationsformater